Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 6419 | 46.86 |
09:34 ET | 400 | 46.93 |
09:36 ET | 2600 | 46.845 |
09:38 ET | 2459 | 46.745 |
09:39 ET | 978 | 46.5574 |
09:41 ET | 22987 | 46.43 |
09:43 ET | 3909 | 46.73 |
09:45 ET | 4592 | 46.68 |
09:48 ET | 4038 | 46.835 |
09:50 ET | 1900 | 46.805 |
09:52 ET | 6427 | 46.83 |
09:54 ET | 3931 | 47.07 |
09:56 ET | 2801 | 47 |
09:57 ET | 50803 | 47 |
09:59 ET | 1200 | 47.035 |
10:01 ET | 55970 | 47.02 |
10:03 ET | 2727 | 47.035 |
10:06 ET | 32416 | 46.94 |
10:08 ET | 3644 | 46.78 |
10:10 ET | 1300 | 46.805 |
10:12 ET | 3058 | 46.72 |
10:14 ET | 1200 | 46.73 |
10:15 ET | 11986 | 46.855 |
10:17 ET | 300 | 46.865 |
10:19 ET | 3809 | 46.94 |
10:21 ET | 1362 | 46.89 |
10:24 ET | 1200 | 47.0075 |
10:26 ET | 200 | 46.975 |
10:28 ET | 100 | 47.02 |
10:30 ET | 2597 | 46.94 |
10:32 ET | 800 | 46.94 |
10:33 ET | 100 | 46.94 |
10:35 ET | 2232 | 46.89 |
10:37 ET | 2252 | 46.885 |
10:39 ET | 4253 | 47.005 |
10:42 ET | 400 | 47.015 |
10:44 ET | 2360 | 46.995 |
10:46 ET | 33686 | 47.215 |
10:48 ET | 7552 | 47.235 |
10:50 ET | 2037 | 47.08 |
10:51 ET | 500 | 47.105 |
10:53 ET | 2170 | 47.04 |
10:55 ET | 100 | 47.04 |
10:57 ET | 2274 | 46.94 |
11:00 ET | 8308 | 46.94 |
11:02 ET | 800 | 46.945 |
11:04 ET | 1877 | 46.83 |
11:06 ET | 1944 | 46.835 |
11:08 ET | 661 | 46.835 |
11:09 ET | 3421 | 46.78 |
11:11 ET | 1365 | 46.78 |
11:13 ET | 6751 | 46.82 |
11:15 ET | 6356 | 46.84 |
11:18 ET | 700 | 46.8275 |
11:20 ET | 1984 | 46.89 |
11:22 ET | 548 | 46.88 |
11:24 ET | 400 | 46.865 |
11:26 ET | 300 | 46.865 |
11:27 ET | 1100 | 46.88 |
11:29 ET | 1400 | 46.925 |
11:31 ET | 3564 | 46.8 |
11:33 ET | 2620 | 46.85 |
11:36 ET | 300 | 46.855 |
11:38 ET | 1059 | 46.82 |
11:40 ET | 844 | 46.79 |
11:42 ET | 2403 | 46.79 |
11:44 ET | 2000 | 46.71 |
11:45 ET | 336 | 46.69 |
11:47 ET | 3000 | 46.745 |
11:49 ET | 500 | 46.75 |
11:51 ET | 1676 | 46.645 |
11:54 ET | 3233 | 46.62 |
11:56 ET | 1395 | 46.65 |
11:58 ET | 1980 | 46.55 |
12:00 ET | 300 | 46.56 |
12:02 ET | 5129 | 46.5 |
12:03 ET | 2579 | 46.47 |
12:05 ET | 1047 | 46.56 |
12:09 ET | 500 | 46.56 |
12:12 ET | 2292 | 46.38 |
12:14 ET | 4837 | 46.34 |
12:16 ET | 1129 | 46.35 |
12:18 ET | 3412 | 46.34 |
12:20 ET | 785 | 46.33 |
12:21 ET | 4449 | 46.35 |
12:23 ET | 615 | 46.317 |
12:25 ET | 2137 | 46.335 |
12:27 ET | 2059 | 46.3621 |
12:30 ET | 1486 | 46.38 |
12:32 ET | 2147 | 46.395 |
12:34 ET | 2500 | 46.35 |
12:38 ET | 900 | 46.39 |
12:39 ET | 1372 | 46.3534 |
12:41 ET | 962 | 46.28 |
12:43 ET | 2162 | 46.325 |
12:45 ET | 1600 | 46.23 |
12:48 ET | 1200 | 46.25 |
12:50 ET | 2618 | 46.16 |
12:52 ET | 5324 | 46.16 |
12:54 ET | 1750 | 46.15 |
12:56 ET | 3516 | 46.17 |
12:57 ET | 3280 | 46.22 |
12:59 ET | 1222 | 46.22 |
01:01 ET | 1500 | 46.19 |
01:03 ET | 621 | 46.215 |
01:08 ET | 4080 | 46.197 |
01:10 ET | 1836 | 46.19 |
01:12 ET | 1100 | 46.2 |
01:14 ET | 1665 | 46.195 |
01:15 ET | 5931 | 46.1 |
01:17 ET | 800 | 46.15 |
01:19 ET | 400 | 46.16 |
01:21 ET | 2850 | 46.18 |
01:24 ET | 608 | 46.145 |
01:26 ET | 1934 | 46.122 |
01:28 ET | 1507 | 46.08 |
01:30 ET | 1700 | 46.08 |
01:32 ET | 1006 | 46.125 |
01:33 ET | 900 | 46.11 |
01:35 ET | 1437 | 46.04 |
01:37 ET | 2694 | 46.05 |
01:39 ET | 2997 | 46 |
01:42 ET | 800 | 46.01 |
01:44 ET | 2162 | 45.95 |
01:46 ET | 300 | 45.96 |
01:48 ET | 4279 | 45.95 |
01:50 ET | 5006 | 46.02 |
01:51 ET | 1600 | 46.13 |
01:53 ET | 2419 | 46.08 |
01:55 ET | 2895 | 46.11 |
01:57 ET | 659 | 46.07 |
02:00 ET | 100 | 46.08 |
02:02 ET | 2040 | 46.05 |
02:04 ET | 1400 | 46.07 |
02:06 ET | 3542 | 46.1529 |
02:08 ET | 1600 | 46.14 |
02:09 ET | 900 | 46.21 |
02:11 ET | 2437 | 46.15 |
02:13 ET | 3693 | 46.08 |
02:15 ET | 2741 | 46.04 |
02:18 ET | 2006 | 46.09 |
02:20 ET | 5327 | 46.03 |
02:22 ET | 1200 | 46.03 |
02:24 ET | 1658 | 46.01 |
02:26 ET | 800 | 46 |
02:27 ET | 1896 | 45.96 |
02:29 ET | 3345 | 45.95 |
02:31 ET | 2532 | 45.9 |
02:33 ET | 4540 | 45.87 |
02:36 ET | 23734 | 45.7952 |
02:38 ET | 1200 | 45.83 |
02:40 ET | 2168 | 45.88 |
02:42 ET | 8838 | 45.86 |
02:44 ET | 1959 | 45.92 |
02:45 ET | 1152 | 45.885 |
02:47 ET | 2243 | 45.88 |
02:49 ET | 8883 | 45.79 |
02:51 ET | 2518 | 45.835 |
02:54 ET | 2425 | 45.795 |
02:56 ET | 3895 | 45.84 |
02:58 ET | 2496 | 45.83 |
03:00 ET | 100 | 45.84 |
03:02 ET | 3175 | 45.81 |
03:03 ET | 17011 | 45.92 |
03:05 ET | 2712 | 45.84 |
03:07 ET | 800 | 45.9 |
03:09 ET | 10120 | 45.86 |
03:12 ET | 5183 | 45.91 |
03:14 ET | 2716 | 46.04 |
03:16 ET | 2200 | 46.005 |
03:18 ET | 7831 | 45.95 |
03:20 ET | 2600 | 45.98 |
03:21 ET | 3611 | 46.02 |
03:23 ET | 1700 | 45.99 |
03:25 ET | 6070 | 45.94 |
03:27 ET | 1800 | 45.99 |
03:30 ET | 1284 | 45.96 |
03:32 ET | 4437 | 45.93 |
03:34 ET | 3071 | 45.9 |
03:36 ET | 2248 | 45.84 |
03:38 ET | 3732 | 45.85 |
03:39 ET | 1100 | 45.87 |
03:41 ET | 6124 | 45.81 |
03:43 ET | 4521 | 45.74 |
03:45 ET | 13161 | 45.73 |
03:48 ET | 8216 | 45.77 |
03:50 ET | 6690 | 45.88 |
03:52 ET | 10638 | 45.87 |
03:54 ET | 21876 | 45.95 |
03:56 ET | 25713 | 46.26 |
03:57 ET | 27545 | 46.27 |
03:59 ET | 121164 | 46.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 8.6B | -15.6x | --- |
Ascendis Pharma A/S | 8.1B | -15.4x | --- |
Cerevel Therapeutics Holdings Inc | 7.7B | -15.9x | --- |
Intra-Cellular Therapies Inc | 7.0B | -49.6x | --- |
Viking Therapeutics Inc | 7.1B | -69.3x | --- |
Cytokinetics Inc | 7.0B | -12.4x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.6B |
---|---|
Revenue (TTM) | $285.1M |
Shares Outstanding | 181.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-2.95 |
Book Value | $6.88 |
P/E Ratio | -15.6x |
Price/Sales (TTM) | 30.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -185.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.